Endocrine and Metabolic Comorbidities in Juvenile-Onset Systemic Lupus Erythematosus

    February 2025 in “ Frontiers in Medicine ”
    Su Jin Park, Moon Bae Ahn, Dae Chul Jeong
    Studysummary This study found that patients with juvenile-onset systemic lupus erythematosus have a high prevalence of endocrine and metabolic comorbidities, particularly dyslipidemia and obesity-related issues, suggesting the need for routine monitoring and obesity prevention.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on public-pages-files-2025.frontiersin.org →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Management of Endocrine Disease: Diagnosis and Management of Primary Amenorrhea and Female Delayed Puberty European journal of endocrinology · 2021
    2. The British Society for Rheumatology Guideline for the Management of Systemic Lupus Erythematosus in Adults Rheumatology · 2017
    3. Mucocutaneous Manifestations in Juvenile-Onset Systemic Lupus Erythematosus: A Review of Literature Pediatric Rheumatology · 2015
    4. Derivation And Validation Of The Systemic Lupus International Collaborating Clinics Classification Criteria For Systemic Lupus Erythematosus Arthritis & Rheumatism · 2012